Clinical Trial Update: CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve System

View source ↗

Summary

The CENTERA PMCF post-market follow-up study for the CENTERA Transcatheter Heart Valve System has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• CENTERA Transcatheter Heart Valve System

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Stenosis | Status: COMPLETED